Routine assessment of the gut microbiome to promote preclinical research reproducibility and transparency by Wardill, H. et al.
ACCEPTED VERSION 
 
 Hannah R Wardill, Joanne M Bowen, Ysabella ZA Van Sebille, Rachel J GibsonBoyle 
 Routine assessment of the gut microbiome to promote preclinical research 
reproducibility and transparency 
Gut, 2017; 66(10):1869-1871 
 “This article has been accepted for publication in Gut, 2017 following peer review, and the 
Version of Record can be accessed online at http://dx.doi.org/10.1136/gutjnl-2016-313486.” 
© Authors (or their employer(s)) 2017. “Reuse of this manuscript version (excluding any 
databases, tables, diagrams, photographs and other images or illustrative material included 
where a another copyright owner is identified) is permitted strictly pursuant to the terms of 





























As the author you may wish to post your article in a PrePrint service, institutional or subject repository 
or a scientific social sharing network. To see BMJs self-archiving policy on these archiving services 
please select the licence type your article was published under: 




2 October 2018 
ROUTINE ASSESSMENT OF THE GUT MICROBIOME TO PROMOTE PRECLINICAL 
RESEARCH REPRODUCIBILITY AND TRANSPARENCY 
Hannah R Wardill1,2, Joanne M Bowen1, Ysabella ZA Van Sebille1 and Rachel J Gibson3.  
1 School of Medicine, University of Adelaide  
2 Centre for Nutrition and Gastrointestinal Diseases, South Australian Health and Medical Research 
Institute (SAHMRI) 
3 Division of Health Sciences, University of South Australia  
 
Corresponding Author  
Dr Hannah Wardill 
South Australian Health and Medical Research Institute (SAHMRI); Department of Nutrition and Metabolism  
North Terrace 




Phone: 08 8128 4842 
 
Key words: gut microbiome, microbiota, breeding facility, TLR4  
Word count: 594 




The irreproducibility of preclinical, biomedical research is becoming increasingly problematic, as 
recently highlighted by Omary et al., (2016) in the June issue of Gut. As discussed in this paper, 
variations in study design, mouse strain, sex and age are important factors that should be adequately 
described to promote study reproducibility [1]. However recent speculation suggests the gut 
microbiome may also confound preclinical research outcomes [2]. Adequate recognition of this 
potential confounder is particularly important with the large volume of studies now reporting 
associations between the gut microbiome and various pathologies, of both gastrointestinal (GI) and 
non-GI origin.   
The gut microbiome is highly plastic, with its composition dependent on genotype and environment 
[2]. In vivo embryo transfer, with genetically distinct embryos, results in similar microbial profiles 
regardless of genetic background [3]. Similarly, relocation of infant mice dramatically changes the 
native microbial community [3]. In adult mice, viable counts of the total bacterial load have revealed 
large differences in the gut microbiome among animals from different facilities [4]. Furthermore, 
differences in the relative abundance of particular microbes have been identified in animals 
originating from different breeding rooms, within the same facility [2]. This critically highlights the 
need to routinely characterise the composition of the gut microbiome to promote study 
reproducibility.  
We have previously shown shown genetic knockout of the innate immune receptor, Toll-like receptor 
4 (TLR4; BALB/c-Tlr4-/-billy), alters the composition of the caecal microbiota. Following introduction 
of a new breeding facility for this genetically modified strain, we assessed the composition of the gut 
microbiome in this new population. In keeping with previous recommendations, efforts were made to 
reduce environmental confounders. Female mice (n=12, BALB/c background, 18-20 g, 8-10 weeks) 
were group housed in ventilated cages, in the same rack/room, with six animals per cage. All animals 
were allowed to acclimitise for 1 week (at the University of Adelaide) during which they were 
exposed to the same dark/light conditions (12 h) and given access to water and food ad libitum. The 
first population of BALB/c- Tlr4-/-billy mice were obtained from the University of Adelaide Laboratory 
Animal Service (TLR4KO1). The second population of BALB/c-Tlr4-/-billy mice were sourced from 
University of Newcastle (TLR4KO2). Both populations were originally sourced from Osaka, Japan. 
The caecal contents were aseptically collected and sent for genetic sequencing at the Australian 
Genomics Research Facility (Brisbane, Australia).  
Consistent with previous in vivo research, our data indicate that breeding facility alters the 
composition of the gut microbiome. In this instance, TLR4KO1 has significantly lower levels of 
Bacteroidetes compared to TLR4KO2 (** P = 0.009, Figure 1). TLR4KO1 mice displayed higher 
levels of gram-positive Actinobacteria (TLR4KO1 2.23 ± 0.63 %; TLR4KO2 60.38 ± 0.07 % Figure 
1, * P = 0.03) and the pathogenic microbe, Proteobacteria (TLR4KO1 3.54 ± 0.90 %; TLR4KO2 1.03 
± 0.25 % Figure 1, * P = 0.03). Fewer total species were also reported in TLR4KO1 (total = 69) 
compared TLR4KO2 (total = 104), although no changes were seen in alpha diversity (Figure 2). 
Given efforts to reduce additional confounders, this supports previous research showing altered 
microbial phenotype in mice from different breeding facilities and even different rooms within the 
same facility [2] and suggests the gut microbiome reflects the cumulative effects of various 
environmental factors. The mechanism(s) underlying these changes are unclear, however our results 
highlight the importance of consistent rodent husbandry when designing and conducting preclinical 
studies, and the need to routinely characterise the composition of the gut microbiome. This is 
especially important with current calls to address the irreproducibility of preclinical research, and 
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Figure Legends  
Figure 1 Breeding conditions affect gut microbiome composition in the BALB/c mouse. (A) 
Relative abundance (%) of bacteria phyla in n = 6 TLR4KO1 and n = 6 TLR4KO2 mice. (B) Mean 
percentage of each bacteria phyla in TLR4KO1 and TLR4KO2 populations. Differences were 
identified in Actinobacteria (TLR4KO1 2.23 ± 0.63 %; TLR4KO2 60.38 ± 0.07 %, * P = 0.03), 
Bacteroidetes (TLR4KO1 13.34 ± 3.47 %; TLR4KO2 27.75 ± 2.75 %, ** P = 0.009) and 
Proteobacteria (TLR4KO1 3.54 ± 0.90 %; TLR4KO2 1.03 ± 0.25 %, * P = 0.03). Data presented as 
individual data points with mean ± SEM.  
 
Figure 2 Shannon’s Diversity Index for TLR4KO1 and TLR4KO2 caecal microbiome species. 
An unpaired t-test with Welch’s correction showed no significant difference between populations of 
BALB/c-Tlr4-/-billy mice. Data presented as individual data points with mean ± SEM; n = 6 per group, 
P > 0.05.  
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